B A Perkins
Overview
Explore the profile of B A Perkins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
3487
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brock C, Andersen H, Alibegovic A, Andersen S, Andreasen L, Charles M, et al.
Diabetes Res Clin Pract
. 2025 Jan;
221:112010.
PMID: 39855602
Background: Diabetic neuropathy (DN) affects up to half of individuals with type 1 and type 2 diabetes. Despite evidence that improving metabolic and cardiovascular health can slow its progression, DN...
2.
Lytvyn Y, Bjornstad P, Katz A, Singh S, Godoy L, Chung L, et al.
Diabetes Metab
. 2019 Dec;
46(3):203-209.
PMID: 31816431
Aims: Copeptin, a surrogate of vasopressin, is elevated in type 1 diabetes (T1D) and predicts kidney disease and cardiovascular mortality. Given the cardiorenal protective effects of SGLT2 inhibition (SGLT2i), our...
3.
ABraham A, Barnett C, Katzberg H, Lovblom L, Perkins B, Bril V
Eur J Neurol
. 2017 Dec;
25(3):484-490.
PMID: 29194856
Background And Purpose: The Toronto Clinical Neuropathy Score (TCNS) is a valid and reliable scale for the diagnosis and staging of diabetic sensorimotor polyneuropathy. In this study, we aimed to...
4.
Lytvyn Y, Skrtic M, Yang G, Lai V, Scholey J, Yip P, et al.
Diabet Med
. 2015 Dec;
33(8):1102-11.
PMID: 26670339
Aims: Increased plasma uric acid (PUA) levels are associated with impaired renal function in patients with Type 1 diabetes, but the mechanisms are not well understood. Our aim was to...
5.
Mohajeri S, Perkins B, Brubaker P, Riddell M
Diabet Med
. 2015 May;
32(11):1425-37.
PMID: 25962798
Although regular physical activity is encouraged for individuals with diabetes, exercise at high altitude increases risk for a number of potential complications. This review highlights our current understanding of the...
6.
Wu T, Ahmed A, Bril V, Orszag A, Ng E, Nwe P, et al.
Diabet Med
. 2012 Apr;
29(9):e297-303.
PMID: 22519850
Aim: Corneal confocal microscopy is a promising screening method for diabetic neuropathy. Although much research in this field has been accomplished, we aimed to determine and confirm the known clinical...
7.
Tesfaye S, Vileikyte L, Rayman G, Sindrup S, Perkins B, Baconja M, et al.
Diabetes Metab Res Rev
. 2011 Jun;
27(7):629-38.
PMID: 21695762
Painful diabetic peripheral neuropathy (DPN) is common, is associated with significant reduction in quality of life and poses major treatment challenges to the practising physician. Although poor glucose control and...
8.
Hertz P, Bril V, Orszag A, Ahmed A, Ng E, Nwe P, et al.
Diabet Med
. 2011 Mar;
28(10):1253-60.
PMID: 21434993
Aim: With the goal of identifying a valid biomarker of early diabetic sensorimotor polyneuropathy, we aimed to identify the most reliable in vivo corneal confocal microscopy (CCM) parameter for detection...
9.
Cherney D, Sochett E, Dekker M, Perkins B
Diabet Med
. 2010 Nov;
27(12):1358-65.
PMID: 21059087
Aims: Systematic study of hyperfiltration in diabetic nephropathy has been hindered by the lack of a simple glomerular filtration rate (GFR) measure that is accurate in this range of renal...
10.
Perkins B, Dholasania A, Buchanan R, Bril V
Diabet Med
. 2010 Oct;
27(11):1271-9.
PMID: 20950385
Aims: Randomized clinical trials have frequently shown improvement in diabetic sensorimotor polyneuropathy in placebo-treated participants, counter to the prevailing concept that it deteriorates with time. We aimed to determine the...